PHC3 COST-EFFECTIVENESS ANALYSIS OF PIMOBENDAN COMPARED TO BENAZEPRIL FOR THE TREATMENT OF ACQUIRED MYXOMATOUS MITRAL VALVE DISEASE IN DOGS IN GERMANY
May 1, 2009, 00:00
10.1016/S1098-3015(10)73371-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)73371-4/fulltext
Title :
PHC3 COST-EFFECTIVENESS ANALYSIS OF PIMOBENDAN COMPARED TO BENAZEPRIL FOR THE TREATMENT OF ACQUIRED MYXOMATOUS MITRAL VALVE DISEASE IN DOGS IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73371-4&doi=10.1016/S1098-3015(10)73371-4
First page :
Section Title :
Open access? :
No
Section Order :
803